Scientific Advisory Board

Scientific Advisory Boards are the main instrument used by the Max Planck Society for the regular evaluation of its research facilities. The Scientific Advisory Board is composed of internationally recognized scientists and it functions as an external advisory committee regarding the scientific performance and administrative development of the Institute. The Scientific Advisory Board evaluates the work of the Institute every three years.

Name

Institution

Country

John Briggs

European Molecular Biology Laboratory

Germany

Colette Dehay

Stem Cell and Brains Research Institute

France

Richard Durbin

Wellcome Trust Sanger Institute

UK

Jean Gruenberg

University of Geneva

Switzerland

Douglas A. Lauffenburger

Massachusetts Institute of Technology

USA

Ruth Lehmann (Chair of the SAB)

Howard Hughes Medical Institute

USA

Maria Leptin

Universität zu Köln

Germany

Justin E. Molloy

MRC National Institute for Medical Research

UK

Alexander van Oudenaarden

Massachusetts Institute of Technology

USA
Aurélien RouxUniversity of GenevaSwitzerland
Konrad SandhoffUniversität BonnGermany
Jason SwedlowUniversity of DundeeUK
Toshio YanagidaOsaka UniversityJapan

Board of Trustees

The Board of Trustees supports the Institute and fosters links between the public and the MPI-CBG. The members of the Board of Trustees are representatives from the local politics, industry, science, and the media, and they are appointed by the President of the Max Planck Society. The Board meets once a year at the Institute and the Managing Director reports about news, outreach activities and latest developments in general.